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Down-Regulation of TIMP2 by HIF-1a/
miR-210/HIF-3a Regulatory Feedback
Circuit Enhances Cancer Metastasis in
Hepatocellular Carcinoma
Alan Ka-Lun Kai,1,2 Lo Kong Chan,1,2 Regina Cheuk-Lam Lo,1,2 Joyce Man-Fong Lee,1,2 Carmen Chak-Lui Wong,1,2
Jack Chun-Ming Wong,1,2 and Irene Oi-Lin Ng1,2
Cancer metastasis is a multistep process that involves a series of tumor-stromal interaction, including extracellular matrix
(ECM) remodeling, which requires a concerted action of multiple proteolytic enzymes and their endogenous inhibitors.
This study investigated the role of tissue inhibitor of metalloproteinases (TIMP) 2 in the context of hepatocellular carci-
noma (HCC) metastasis. We found that TIMP2 was the most signiﬁcantly down-regulated member among the TIMP
family in human HCCs. Moreover, TIMP2 underexpression was frequent (41.8%; 23 of 55) in human HCCs and was sig-
niﬁcantly associated with liver invasion and poorer survival outcomes of HCC patients. Furthermore, stable silencing of
TIMP2 in HCC cell lines enhanced cell invasive ability and ECM degradation associated with formation of invadopodia-
like feature, suggesting that TIMP2 is a negative regulator of HCC metastasis. Using an orthotopic tumor xenograft
model, we demonstrated that ectopic expression of TIMP2 open reading frame in the highly metastatic HCC cell line,
MHCC-97L, signiﬁcantly reduced HCC progression as well as pulmonary metastasis. Mechanistically, TIMP2 suppres-
sion, in a hypoxic environment, was induced through a regulatory feedback circuit consisting of hypoxia-inducible factor
(HIF) 1 alpha, microRNA-210 (miR-210), and HIF-3a. Conclusion: TIMP2 is frequently down-regulated in human
HCCs and its down-regulation is associated with aggressive tumor behavior and poorer patient outcome. Its suppression
is under the regulation of a novel feedback circuit consisting of HIF-1a/miR-210/HIF-3a. TIMP2 is an important regula-
tor of ECM degradation and HCC metastasis. (HEPATOLOGY 2016;64:473-487)
Liver cancer (hepatocellular carcinoma; HCC) isone of the most common fatal cancers world-wide,(1) being the third-leading cause of cancer
deaths in the world and the second-leading cause of
cancer deaths in China and Southeast Asia.(2) The
poor prognosis of this disease is mainly attributable to
the high rate of tumor recurrence or metastasis, con-
tributing to around 90% of cancer-related mortality.(3)
Hypoxia is a prevalent tumor microenvironment in
HCC, attributed to the insufﬁcient vascular networks
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to support the rapidly growing tumor. Hypoxia-
inducible factors (HIFs), consisting of an oxygen-
sensitive a subunit (HIFa) and a constitutively
expressed b-unit (HIFb), are one of the most impor-
tant transcriptional regulators that facilitate cellular
response to hypoxia. In humans, three distinct forms
of HIF-a have been identiﬁed (HIF-1a, HIF-2a, and
HIF-3a), and all of them are involved in regulating
transcriptional programs in response to hypoxia.
Cancer metastasis is a complicated process that
involves concerted actions of many transcriptional
regulators and proteolytic enzymes, some of which have
been demonstrated to be regulated by hypoxia and HIFs
in solid tumors. Invasion of the extracellular matrix
(ECM) is an early and essential step of the metastatic
cascade. Matrix metalloproteinases (MMPs) are extrac-
ellular endopeptidases primarily responsible for degrada-
tion of ECM proteins, preparing the path for tumor
cells to invade and migrate across the stroma for distant
metastasis.(4,5) Therefore, inhibition of MMPs may
reduce ECM degradation and suppress dissemination of
primary tumor cells. Apart from activation of zymogen
forms and transcriptional control, activities of MMP
family members are also regulated by their endogenous
inhibitors, namely, the tissue inhibitors of metalloprotei-
nases (TIMPs).(6) Currently, four different members
have been identiﬁed in the TIMP family (TIMP1,
TIMP2, TIMP3, and TIMP4), and their primary func-
tion is to provide extracellular regulation of the proteo-
lytic activities of MMPs.(7) Despite potentially
inhibiting all the MMPs, each TIMP member has dif-
ferent efﬁcacies against different MMP members.
Deregulation of microRNAs (miRNAs) has been
implicated in both promotion and suppression of can-
cer metastasis by functioning as posttranscriptional reg-
ulators of oncogenes or tumor-suppressor genes.(8-11)
Under this study, we sought to explore the contribution
of the miRNA/HIF-1a feedback loop in promoting
the invasive abilities of HCC cells as well as its interac-
tion with TIMP2. Here, we showed that TIMP2 sup-
pression induced invadopodia-like features in HCC
cells, which, in turn, enhanced ECM degradation.
Under hypoxia, TIMP2 was suppressed through a
HIF-1a-dependent mechanism and the suppression
was under regulation of a novel feedback circuit com-
posed of HIF-1a, miR-210, and HIF-3a. Conversely,
inhibition of miR-210 perturbed the feedback circuit,
attenuated the suppression of TIMP2 under hypoxia,
and eventually reduced HCC cell invasion. Our ﬁnd-
ings have provided evidence to show that TIMP2 is an
important negative regulator of cell invasion, and thus
metastasis, and is under regulation of a novel feedback
circuit consisting of HIF-1a/miR-210/HIF-3a.
Materials and Methods
CELL LINES AND HUMAN
SAMPLES
Human HCC cell lines SMMC-7721, PLC/PRF/
5, MHCC-97L, and BEL-7402 were used in the
present study. SMMC-7721 was obtained from the
Shanghai Institute of Cell Biology (Shanghai, China).
PLC/PRF/5 was obtained from the American Type
Culture Collection (Manassas, VA). MHCC-97L was
obtained from Prof. Z.Y. Tang of the Fudan Univer-
sity in Shanghai. All HCC specimens and their corre-
sponding nontumorous liver tissues were resected from
Chinese patients between 1991 and 2007 at Queen
Mary Hospital, Hong Kong. Thirty-nine patients were
male and 16 were female. Ages ranged from 24 to 82
years (mean 5 54.25 years). Overall, 44 of 55 (80%) of
the patients had chronic hepatitis B viral infection with
positive serum hepatitis B surface antigen status. None
of these patients received any other therapies, including
chemoembolization or chemotherapy, before hepatic
tumor resection. After surgical resection, all specimens
were either snap-frozen immediately in liquid nitrogen
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and stored at -808C or ﬁxed in buffered 10% formalin
for parafﬁn embedding. Use of clinical specimens was
approved by the institutional review board of the Uni-
versity of Hong Kong/Hospital Authority.
ESTABLISHMENT OF STABLE
TIMP2 KNOCKDOWN AND
OVEREXPRESSING CELLS
TIMP2 was stably knocked down in HCC cell lines
by means of lentiviral approach as described.(12) In
brief, short hairpin RNA (shRNA) against TIMP2
(shTIMP2-33 or shTIMP2-34) or nontarget control
(shNTC) was cotransfected with the packaging mix
into 293FT cells using Lipofectamine 2000 (Invitro-
gen, Carlsbad, CA) to produce the lentiviral particles.
HCC cells were transduced with the shRNA-
containing or shNTC-containing recombinant lentivi-
rus, and positive transduced cells were selected for at
least two passages by puromycin treatment at a concen-
tration of 1-2 lg/mL. Successful knockdown or
ectopic expression of TIMP2 was conﬁrmed by means
of western blotting. Stable TIMP2-overexpressing
HCC cells were similarly generated. TIMP2 knock-
down vectors were purchased from Sigma-Aldrich (St.
Louis, MO), and TIMP2-overexpressing vector was
purchased from GeneCopoeia (Rockville, MD). HIF-
1a and HIF-2a knockdown (shHIF1a and shHIF2a)
HCC cells were generated in our previous study.(13)
RNA EXTRACTION AND
QUANTITATIVE POLYMERASE
CHAIN REACTION
Total RNA from HCC cell lines or frozen HCC
clinical tissues was extracted using TRIzol reagent
(Invitrogen, Grand Island, NY). Complementary
DNA was synthesized from 1lg of total RNA using
the GeneAmp RNA PCR Kit (Applied Biosystems,
Foster City, CA). Taqman probes for TIMP1,
TIMP2, TIMP3, TIMP4, hypoxanthine-guanine
phosphoribosyltransferase (HPRT), and 18s were pur-
chased from Applied Biosystems. Reverse transcription
of miRNAs was performed using the Taqman Micro-
RNA Reverse Transcription Kit with the microRNA-
speciﬁc primers. All quantitative polymerase chain
reaction (qPCR) reactions were performed in triplicate
using the Taqman Universal PCR Master Mix Kit and
7900 HT Fast Real Time PCR System (Applied
Biosystems).
microRNA EXTRACTION
AND PROFILING
microRNA (miRNA) from SMMC-7721,
MHCC-97L-luc, and PLC/PRF/5 after 48 hours of
incubation at normoxic (20% O2) or hypoxic (0.1%
O2) condition was extracted using TRIzol reagent
(Invitrogen) and subsequently subject to Megaplex
reverse transcription (Applied Biosystems). miRNA
expression proﬁles were examined using the Taqman
human MiRNA Low-Density Array Set (v2.0).
Expression levels were normalized against endogenous
U6 controls. For individual miRNA assay on
formalin-ﬁxed parafﬁn-embedded (FFPE) HCC clini-
cal samples, miRNA extraction was performed as
described.(11) In brief, hypoxic HCC cells in perine-
crotic areas, aided by immunohistochemistry (IHC)
using the hypoxia marker, CA9, were microdissected
by a 27-gauge needle under a dissecting microscope.
miRNA extraction was performed with the miRNeasy
FFPE kit (Qiagen, Valencia, CA).
PLASMIDS AND REAGENTS FOR
LUCIFERASE REPORTER ASSAYS
Transcriptional activity of HIF-1a by luciferase
reporter assay was examined by luciferase reporter assay
as described.(14) In brief, a 60-base-pair minimal frag-
ment of the cytomegalovirus promoter fused with six
copies of consensus sequence of hypoxia-responsive
elements (HREs), tgcatACGTGggctccaa, was sub-
cloned into pGL3 basic luciferase reporter construct.
pRL-SV40 was used as an internal control to normal-
ize transfection efﬁciency. Twenty-four hours after
transfection of the construct, transfected HCC cells
were subject to either normoxia or hypoxia condition
for another 24 hours. Fireﬂy and Renilla luciferase sig-
nals were determined by dual-luciferase reporter assay
(Promega, Madison, WI), according to the manufac-
turer’s protocol. To examine the negative regulatory
role of miR-210 on HIF-3a by luciferase reporter
assay, two copies of either putative wild-type or
mutated miR-210 binding sites of the HIF-3a 30UTR
(untranslated region) were subcloned into the dual-
luciferase miRNA target expression vector, pmirGLO
(Promega). Next, 15 pmole of miR-210 precursor was
transfected into BEL-7402 cells using X-tremeGene
(Roche, Basel, Switzerland). Twenty-four hours later,
0.5 lg of the pmirGLO construct containing the wild-
type or mutated HIF-3a 30UTR-binding sequence was
transfected into BEL-7402 cells using Fugene 9
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(Roche, Indianapolis, IN). Forty-eight hours after the
second transfection, ﬁreﬂy and Renilla luciferase sig-
nals were determined by dual-luciferase reporter assay
as described. Transfection efﬁciency was normalized
with Renilla luciferase activity. Three independent
experiments were performed for each group.
INVASION ASSAYS
In vitro cell invasive ability was examined by trans-
well assays as described.(15) In brief, 5 3 104 cells were
added evenly onto the upper chamber of the transwell,
uncoated for migration assay, or coated with a thin
layer of BD Matrigel Matrix (BD Biocsciences,
Sparks, MD) for invasion assay. After incubation,
migrated and invaded cells were ﬁxed with 100%
methanol and subsequently stained with 0.1% crystal
for assessment. For each experimental group, a mini-
mum of three random ﬁelds of stained cells photo-
graphed by a camera connected to a phase contrast
microscope were counted.
IN VIVO ORTHOTOPIC LIVER
INJECTION MODEL
Six- to 8-week-old BALB/c-nu/nu athymic male
mice were used for in vivo experiments in this study.
Orthotopic liver injection was performed using a 25-
lL syringe with a cemented 22-gauge needle. HCC
cells (1 3 106) were resuspended in 20 lL of matrigel
diluted with serum-free cell culture medium in a 1:1
ratio. Mice were anesthetized with 80 mg/kg of pento-
barbitol and a small incision was made in the abdo-
men. The left lobe of the liver was gently exposed and
the resuspended cells were carefully injected into the
lobe. After injection, the abdominal wound was
sutured.
MHCC-97L cells used for injection were stably
transduced with ﬁreﬂy luciferase gene and enabled reg-
ular in vivo monitoring of tumor growth by biolumi-
nescent imaging. For in vivo signal detection, 100 mg/
kg of D-luciferin (Xenogen, Hopkinton, MA) was
injected intraperitoneally into tumor-bearing mice and
representative bioluminescent images were captured
using an IVIS 100 Imaging System (Xenogen). Ex
vivo imaging of lung was also performed to examine
extrahepatic metastasis of HCC xenografts. All animal
experiments were performed according to the Animals
(Control of Experiments) Ordinance (Hong Kong)
and the institution guidance on animal work.
INVADOPODIA AND
IMMUNOFLUORESCENCE
HCC cells were plated on green ﬂuorescent gelatin-
coated coverslips prepared according to the manu-
facturer’s instruction (Millipore), and invadopodia
formation was examined by confocal microscopy. After
24-48 hours of culture, cells were ﬁxed in 4% parafor-
maldehyde for 30 minutes, followed by immunostain-
ing with phalloidin. Areas of degradation mediated by
HCC clones were examined using a laser scanning
confocal microscope and images were processed using
Photoshop software (Adobe Systems, Newton, MA)
and ImageJ (National Institutes of Health, Bethesda,
MD). To quantitate the percentage of cells associated
with gelatin degradation, a minimum of 200 cells were
scored for each experimental group. Cells were scored
as positive if the F-actin-rich structures colocalized
with an area devoid of green ﬂuorescent gelatin.
CLINICOPATHOLOGICAL
CORRELATION AND
SURVIVAL ANALYSIS
Clinicopathological features were correlated with
the TIMP2 IHC protein expression using SPSS 20 for
Windows (SPSS, Inc., Chicago, IL). The independent
t test was used for continuous parametric data, the
Mann-Whitney U test for continuous nonparametric
data, and the Fisher’s exact test for continuous para-
metric data. Survival data were analyzed using Kaplan-
Meier’s method and compared between groups by the
log-rank test. Differences were considered statistically
signiﬁcant when the P values were less than 0.05.
Results
TIMP2 WAS FREQUENTLY DOWN-
REGULATED IN HUMAN HCCs
From our whole-transcriptome sequencing data on
16 pairs of primary human HCCs and their corre-
sponding nontumorous livers (NTLs), we observed
that TIMP2 was most substantially underexpressed
among all four TIMP family members in HCC tissues
(Fig. 1A). We further examined the expression pattern
of TIMP2 by qPCR in an expanded cohort of 48 pairs
of HCCs and their corresponding NTLs (Fig. 1B).
Consistently, TIMP2 messenger RNA (mRNA) levels
were found to be signiﬁcantly underexpressed in
human HCCs (P < 0.001, Mann-Whitney U test).
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Furthermore, with IHC (Fig. 1C), TIMP2 protein
underexpression was frequently 41.8% (23 of 55)
observed in HCCs. Upon clinicopathological correla-
tion, TIMP2 protein underexpression was signiﬁ-
cantly associated with direct tumor invasion into the
adjacent liver parenchyma (P 5 0.035, Fisher’s exact
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FIG. 1. TIMP2 was the most frequently down-regulated TIMP member in human HCCs. (A) mRNA levels of four TIMP mem-
bers (TIMP1, 22, 23, and 24) normalized with HPRT in an initial cohort of 16 pairs of tumorous (T) and corresponding non-
tumorous (NT) liver tissues from HCC patients (Mann-Whitney U test). (B) mRNA levels of TIMP2 normalized with HPRT in an
expanded cohort of 48 pairs of T and corresponding NT tissues (Mann-Whitney U test; P < 0.001). (C) IHC staining using anti-
body against TIMP2 on human HCCs and their corresponding NT livers. (D) Underexpression of TIMP2 in human HCCs signiﬁ-
cantly correlated with both overall and disease-free survival rates of patients. HCC patients were classiﬁed into two groups according
to underexpression of TIMP2. Survival data were analyzed using Kaplan-Meier’s method.
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test; Table 1). There was a trend of a positive associa-
tion of TIMP2 underexpression and tumor microsa-
tellite formation (P 5 0.067, Fisher’s exact test;
Table 1), although it did not reach statistical signiﬁ-
cance. Furthermore, TIMP2 protein underexpression
in HCCs was associated with signiﬁcantly poorer
overall survival rates (median survival rate of 79.1
months vs. 29.5 months; P 5 0.002) as well as
disease-free survival rates of HCC patients (median sur-
vival rate of 41.3 months vs 15.6 months; P 5 0.016;
Fig. 1D).
KNOCKDOWN OF TIMP2
PROMOTED THE INVASIVE
ABILITY OF HCC CELLS IN VITRO
Given that down-regulation of TIMP2 was fre-
quently observed in patient HCCs and associated
with aggressive behavior and poorer patient survival,
we examined whether knockdown of TIMP2 in
HCC cells would enhance their invasive abilities. We
observed that TIMP2 was differentially expressed
across a panel of HCC cell lines (Supporting Fig.
S1). By lentiviral transduction of shRNA, we estab-
lished stable knockdown TIMP2 clones in HCC cell
lines (SMMC-7721 and PLC/PRF/5), which are
lowly metastatic and have high TIMP2 expression
(Fig. 2A). By transwell Matrigel cell invasion assay,
the number of cells invading the Matrigel chamber
was signiﬁcantly higher in the two independent
TIMP2 knockdown clones, as compared to shNTC.
Similar results were observed in both HCC cell lines
(Fig. 2A,B), suggesting that the proinvasive ability of
TIMP2 knockdown was not cell-line speciﬁc. In
addition, the regulatory role of TIMP1 was also
examined, given that levels of TIMP1 were also
underexpressed in primary HCC tissues. Knockdown
of TIMP1 did not enhance invasive abilities of both
SMMC-7721 and PLC/PRF/5 (Supporting Fig. S2),
suggesting that the preventive role of TIMP2 in
HCC cell invasion is speciﬁc to TIMP2, but not
TIMP1.
Invadopodia are highly regulated and transient sub-
cellular protrusions that represent sites of ECM
attachment as well as degradation.(16) Accumulating
TABLE 1. Clinicopathological Features of 55 HCC Patients Analyzed
Clinicopathological
Features
No. of Cases
Without TIMP2
Underexpression
No. of Cases
With TIMP2
Underexpression P Value
Sex
Male 23 16 0.543
Female 9 7
Tumor size, cm
>5 16 11 0.565
5 15 11
Liver invasion
Absent 21 9 0.035*
Present 7 11
Tumor microsatellite formation
Absent 18 7 0.067
Present 14 15
Tumor encapsulation
Absent 20 18 0.142
Present 11 4
Venous invasion
Absent 13 9 0.602
Present 19 13
Cellular differentiation
Edmondson grade I-II 15 10 0.570
Edmondson grade III-IV 17 12
TNM staging
I-II 11 6 0.416
III-IV 20 15
*Fisher’s exact test.
Abbreviation: TNM, tumor node metastasis.
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evidence suggests that invadopodia highly correlate
with cancer cell invasiveness by promoting ECM deg-
radation and cell motility. Therefore, we examined
whether TIMP2 expression level affected invadopodia
formation and the associated ECM degradation. We
observed microscopically that gelatin degradation,
reminiscent of ECM degradation, was signiﬁcantly
enhanced in TIMP2 knockdown cells (Fig. 2C,D). Of
note, the sites of gelatin degradation appeared to coloc-
alize with cells with F-actin-rich structures, suggesting
that degradation was mediated by invadopodia-like
features (Supporting Fig. S3A,B and Fig. 2C). Again,
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FIG. 2. Knockdown of TIMP2
enhanced cell invasion and inva-
dopodia formation in HCC cells.
(A,B) Western blotting analysis
showed successful knockdown of
TIMP2. Knockdown of TIMP2
resulted in increased cell-invasive
abilities. Transwell cell invasion
assays of (A) SMMC-7721 and
(B) PLC/PRF/5 were performed
after transduction with shNTC
and shTIMP2 lentivirus. Quan-
titative data are presented as
mean 6 SD, and statistical sig-
niﬁcance was determined by t
test (*P < 0.05; **P < 0.01; ***P
< 0.001). Results were from
three independent experiments.
(C,D) Representative immuno-
ﬂuorescence images of (C)
SMMC-7721 and (D) PLC/
PRF/5 plated on ﬂuorescein-
isosthiocyanate-conjugated gelatin
and stained phalloidin. Scale bar,
20 lm. Invadopodia are deﬁned
as gelatin degradation colocalized
with F-actin-rich structures. Per-
centage of cells associated with
gelatin degradation was calculated
as the number of cells with inva-
dopodia normalized to the total
number of cells scored (at least
200 cells were scored per experi-
mental group). Quantitative data
are presented as mean 6 SD,
and statistical signiﬁcance was
determined by t test (*P < 0.05;
**P < 0.01; ***P < 0.001).
Results were from three inde-
pendent experiments. Abbrevia-
tion: DAPI, 40,6-diamidino-2-
phenylindole.
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the effect of TIMP2 suppression in triggering
ECM degradation associated with invadopodia was
not cell-line speciﬁc, given that similar observations
were consistently found in the other HCC cell line,
PLC/PRF/5 (Fig. 2D). These ﬁndings, in line with
the Matrigel invasion assay, emphasized that suppres-
sion of TIMP2 promoted invasive abilities of HCC
cells through enhancing ECM degradation association
with invadopodia-like features.
ECTOPIC EXPRESSION OF TIMP2
SUPPRESSED PULMONARY
METASTASIS OF HCC IN VIVO
Next, we sought to determine whether ectopic
expression of TIMP2 suppressed in vivo distant
metastasis of HCC cells by orthotopic injection of
luciferase-labeled, TIMP2-overexpressing MHCC-
97L cells (TIMP2) and its corresponding empty vector
(EV) control cells. Xenogen imaging clearly revealed a
signiﬁcant reduction in volumes of the TIMP2-
overexpressing tumors as compared to those of the EV
control group (Fig. 3A). Moreover, irregular, invasive
tumor borders at the tumor growth front were
observed in all (5 of 5) of the EV group, as compared
to 60% (3 of 5) of the TIMP2 group. Of note, tumor
microsatellite formation and venous invasion, both
being recognized features of HCC metastasis, were not
observed in any of the tumor xenografts derived from
TIMP2-overexpressing cells, whereas these pathologi-
cal features were observed in most of the tumor xeno-
grafts derived from the EV control group (Fig. 3B,C).
More importantly, lungs harvested from these tumor-
bearing mice with EV tumor xenografts had distinct
metastasis formation in 5 of 5 (100%) mice, as com-
pared to only 1 of 5 (20%) mice with TIMP2-
overexpressing tumor xenografts (Fig. 3D). Formation
of tumor foci in lung tissues was further conﬁrmed by
histological analysis (Fig. 3E).
SUPPRESSION OF TIMP2 BY
HYPOXIA WAS MEDIATED BY
HIF-1a/miR-210/HIF-3a
REGULATORY CIRCUIT
We observed that the expression of TIMP2 was sig-
niﬁcantly reduced in HCC cells under hypoxia (Sup-
porting Fig. S5A and Fig. 4A). However, suppression
of TIMP2 expression was signiﬁcantly abolished upon
knockdown of HIF-1a, but not HIF-2a, indicating
that suppression of TIMP2 by hypoxia was HIF-1a
dependent.
Recently, the importance of miRNA transcription
factor feedback loops has been highlighted in various
human malignancies.(17-19) Therefore, we further in-
vestigated whether speciﬁc miRNA(s) played a regula-
tory role in ﬁne tuning the transcriptional activity of
HIF-1a, which, in turn, down-regulated the expres-
sion of TIMP2 under hypoxia. To this end, we exam-
ined the microRNA expression proﬁles with TaqMan
human microRNA Low-Density Array on three HCC
cell lines (SMMC-7721, Huh-7, and MHCC-97L)
under normoxic and hypoxic conditions and compared
them with the microRNA proﬁle of primary HCC tis-
sues we previously reported on.(20) From the 664
microRNAs examined, miR-210 was commonly over-
expressed in all three HCC cell lines under 0.1% O2
hypoxic condition (Supporting Fig. S4A). Hypoxic
induction of miR-210 was further validated in four
other HCC cell lines (Hep3B, PLC/PRF/5, HLE,
and BEL-7402; Supporting Fig. S4B), as well as in
hypoxic regions, as depicted by CA9 staining, in
human HCC specimens (Supporting Fig. S4C).
Next, we further investigated the regulatory role of
miR-210 on HIF-1a. We inhibited miR-210 using
miR-210-speciﬁc locked nucleic acid (LNA) and
examined HIF-1a transcriptional activities by lucifer-
ase reporter assay. Whereas cells transfected with
(NTC) LNA expectedly displayed a dramatic increase
of HIF-1a-dependent luciferase activity under
hypoxia, induction of the luciferase signal mediated by
hypoxia treatment was signiﬁcantly abolished upon
miR-210 inhibition (Fig. 4B), revealing that miR-210,
as a microRNA induced by HIF-1a (Supporting Fig.
S5B), also regulated HIF-1a transcriptional activity
through a feedback circuit. In line with this observa-
tion, the mRNA and protein levels of TIMP2 were
down-regulated by hypoxia and the down-regulation
was signiﬁcantly abolished upon miR-210 inhibition
(Fig. 4C and Supporting Fig. S5C), implicating that
hypoxic induction of miR-210 is an important media-
tor of TIMP2 suppression in HCC during hypoxia.
By in silico analysis using TargetScan 5.2 and RNA
hybrid miRNA target prediction algorithms, we found
a putative binding site for hsa-miR-210 in the 30UTR
of HIF-3a (Fig. 4D), a classical dominant-negative
regulator of HIF-1a.(21,22) With luciferase reporter
assay to test whether miR-210 induction modulated
HIF-1a signaling by a feedback mechanism by repres-
sing HIF-3a, transfection of the miR-210 precursors
signiﬁcantly suppressed the signal of the wild-type
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HIF-3a 30UTR-coupled luciferase reporter construct
by 40%, as compared to the NTC control (Fig. 4D).
This suppressive effect was substantially abolished
when the putative miR-210-binding site was mutated,
revealing that miR-210 bound to the 30UTR of HIF-
3a in HCC cells and that HIF-3a is a bona-ﬁde target
of miR-210 in human HCCs.
We postulated that ectopic overexpression of HIF-
3a with no 30UTR might disturb the regulatory circuit
and modulate HIF-1a transcriptional activity. As
revealed by luciferase reporter assays, overexpression of
HIF-3a mimicked the effect of miR-210 inhibition
and resulted in a signiﬁcant decrease in HIF-1a tran-
scriptional activity (Supporting Fig. S5D and Fig. 4E).
In line with this observation, the level of miR-210
under hypoxia was also signiﬁcantly reduced in HIF-
3a-overexpressing cells compared to those in EV con-
trol cells (Fig. 4F). Taken altogether, the data suggest
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FIG. 3. Ectopic expression of
TIMP2 suppressed HCC pro-
gression and pulmonary metasta-
sis in vivo. (A) Xenogen imaging
of nude mice subject to ortho-
topic liver injection of EV and
the open reading frame of
TIMP2 in MHCC-97L cells are
shown. MHCC-97L cells stably
overexpressing luciferase were
used for the orthotopic injection
model. (B) Representative H&E
sections of hepatic tumor xeno-
grafts are shown. Tumor micro-
satellite formation around primary
tumor xenografts and multiple
foci of venous invasion were
frequently observed in the EV
control group, but not in the
TIMP2-overexpressing group.
Black arrow indicates venous
invasion and white arrows indi-
cate the tumor boundary. (C)
Summary of pathological analysis
on hepatic tumor xenografts
derived from EV control and
TIMP2-overexpressing MHCC-
97L cells in nude mice. (D) Ex
vivo bioluminescent imaging of
lung tissues harvested from
tumor-bearing mice is shown.
Presence of pulmonary metastasis
was detected by luciferase signals.
Formation of pulmonary metas-
tases was signiﬁcantly reduced in
nude mice bearing hepatic tumor
xenografts with TIMP2 overex-
pression, as compared to the EV
control group. (E) Representative
H&E sections of lung tissues
conﬁrmed the presence of metas-
tases in the EV control group,
as compared to none in the
TIMP2-overexpressing group.
Abbreviation: H&E, hematoxy-
lin and eosin.
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FIG. 4. Suppression of TIMP2 by hypoxia was mediated by HIF-1a/miR-210/HIF-3a regulatory circuit in human HCCs. (A)
Hypoxic suppression of TIMP2 was abolished upon HIF-1a knockdown, but not HIF-2a knockdown. mRNA levels of TIMP2 in
shNTC, shHIF-1a, and shHIF-2a MHCC-97L clones were determined by qPCR and normalized to HPRT (P < 0.050, t test;
mean 6 SD; n 5 3). (B) miR-210 inhibition suppressed the transcriptional activity of HIF-1a. Luciferase reporter assay demonstrated
that miR-210 inhibition suppressed the activity of HRE-luciferase reporter construct under hypoxia (P < 0.001, t test; mean 6 SD).
(C) qPCR analysis of TIMP2 levels in SMMC-7721 cells, subject to transfection with negative control (NC) LNA inhibitor or miR-
210 LNA inhibitor and incubated under normoxia (20% O2) or hypoxia (0.1% O2; P < 0.010, t test). (D) In silico analysis (i) RNA
hybrid and (ii) TargetScan 5.2 revealed a putative miR-210 target sequence in the 30UTR of HIF-3a. This fragment was fused with
the pmiRGLO vector to examine the binding by luciferase reporter assay. The mutated seed sequence is underlined. (iii) miRNA
luciferase reporter assay. pmiRGLO luciferase reporter fused with two copies of wild-type miR-210 target sequences were transfected
into BEL-7402 cells after transfection with NC precursor or miR-210 precursor. miR-210 precursor signiﬁcant suppressed luciferase
activity of wild-type 30UTR of HIF-3a (P < 0.001, t test; mean 6 SD; n 5 5). (E) Luciferase reporter assay demonstrated that
ectopic expression of HIF-3a ORF suppressed activity of HRE-luciferase reporter construct under hypoxia (P < 0.001, t test; mean
6 SD; n 5 5). (F) Ectopic expression of HIF-3a ORF suppressed hypoxic induction of mR-210. Transcript levels of miR-210 in
SMMC7721 stably expressing the empty vector GFP or HIF-3a ORF are shown. U6 was used as a housekeeping gene for data nor-
malization (P < 0.010, t test; mean 6 SD; n 5 3). Abbreviations: GFP, green ﬂuorescent protein; ORF, open reading frame; RLU,
relative light units.
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that TIMP2 is down-regulated by hypoxia through a
HIF-1a/miR-210/HIF-3a regulatory feedback circuit.
ENHANCED CELL INVASION
CONFERRED BY SUPPRESSION
OF TIMP2 WAS PERTURBED BY
miR-210 INHIBITION IN HYPOXIC
HCC CELLS
Given that HIF-1a signaling is tightly regulated by
miR-210 and its direct target HIF-3a in hypoxic
HCC cells, we postulated that suppression of TIMP2
under hypoxia was mediated by a feedback circuit that
might involve HIF-1a/miR-210/HIF-3a. Therefore,
we sought to investigate whether miR-210 inhibition
would attenuate suppression of TIMP2 mediated by
hypoxia and thus reduce HCC cell-invasive ability.
First, we observed that overexpression of miR-210
was prevalent in HCC patients (34.0% [18 of 53];
P < 0.001) and signiﬁcantly associated with poorer
survival with shorter overall and disease-free survival
rates (P < 0.001 and P 5 0.011, respectively;
Fig. 5A,B). Overexpression of miR-210 in human HCC
tissues was signiﬁcantly correlated with TIMP2 protein
underexpression (P 5 0.018), further supporting that
miR-210 plays a regulatory role in TIMP2 expression in
human HCC (Table 2). Clinicopathological analysis
revealed that miR-210 overexpression was signiﬁcantly
associated with aggressive behavior, including advanced
tumor stages (P 5 0.009), presence of venous invasion
(P 5 0.022), and absence of tumor encapsulation (P 5
0.002; Fig. 5C). The prometastatic role of miR-210 was
further examined by Matrigel transwell cell invasion
assay. In addition, the SMMC-7721 and BEL-7402
HCC clones stably overexpressing miR-210 by lentiviral
infection showed signiﬁcantly enhanced cell-invasive
abilities in these cells even under the normoxic condition
(Fig. 5D), suggesting that miR-210 plays a stimulatory
role in HCC metastasis.
It has been well documented that metastatic poten-
tial of various human cancers is greatly enhanced under
hypoxic conditions. Invasive abilities of both SMMC-
7721 cells and PLC/PRF/5 were signiﬁcantly enhanced
under hypoxic conditions. However, when we transi-
ently repressed miR-210 levels using the speciﬁc LNA
inhibitor, enhancement of cell-invasive abilities by
hypoxia was remarkably abolished in each of these cell
lines, and the suppressive effect of miR-210 inhibition
was not observed in TIMP2 knockdown clones
(Fig. 6A-C), highlighting that TIMP2 is a crucial
mediator for suppressing cell invasion conferred by
miR-210 inhibition. In line with these observations,
we also demonstrated that the ECM degradation asso-
ciated with invadopodia formation was also signiﬁ-
cantly enhanced in hypoxic HCC cells (Supporting
Fig. S6). Similarly, miR-210 inhibition signiﬁcantly
attenuated enhancement of ECM degradation con-
ferred by hypoxia, and knockdown of TIMP2 evi-
dently reversed the suppressive effect of miR-210
inhibition.
Discussion
In this study, we found that TIMP2 was frequently
and signiﬁcantly down-regulated in human HCCs as
compared to corresponding NTLs. Moreover, down-
regulation of TIMP2 signiﬁcantly correlated with
direct liver invasion into the adjacent liver parenchyma
by the tumor. In line with this observation, we showed
that knockdown of TIMP2 promoted HCC cell inva-
sion in vitro as well as ECM degradation mediated by
formation of invadopodia-like features. Furthermore,
our in vivo orthotopic tumor cell injection model dem-
onstrated that ectopic expression of TIMP2 in highly
metastatic HCC cells not only reduced the incidence
of tumor microsatellite formation and venous invasion
in the primary hepatic tumor xenografts, but also pul-
monary metastasis, suggesting that both extrahepatic
and intrahepatic metastasis in HCC was affected by
TIMP2 expression. Taken together, our study has pro-
vided solid in vitro and in vivo evidence that TIMP2
is an important regulator of HCC metastasis.
ECM degradation is an early and essential step in
cancer metastasis, which is a key factor for determining
patient survival that contributes to around 90% of mor-
tality associated with different types of solid tumor.(3)
The MMP/TIMP system is a critical regulator of
ECM remodeling in the context of both normal physi-
ological and pathological tissue compositions. It is well
known that the imbalance between different members
of MMP and TIMP can facilitate ECM degradation
in malignant cells.(5) In line with this phenomenon, we
found that down-regulation of TIMP2 protein signiﬁ-
cantly correlated with poorer survival of HCC patients.
This clinical association implicates that further under-
standing of how TIMP2 was down-regulated may pro-
vide therapeutic strategy for improving patient survival
by antagonizing HCC cell invasion. In the present
study, we demonstrated that TIMP2 was suppressed
by hypoxia, and this is likely to be an important
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FIG. 5. Overexpression of miR-210 in human HCCs was associated with poorer survival rates and aggressive tumor behavior. (A)
Overexpression of miR-210 was frequent in human HCCs (34.0%; 18 of 53). Expression of mature miR-210 in a cohort of 53 HCC
patients was determined by qPCR and normalized against endogenous control U6. (B) Overexpression of miR-210 in human HCCs
was associated with both shorter overall and disease-free survival rates. HCC patients were classiﬁed into two groups according to the
expression of miR-210. Overexpression indicates a log2 fold change 11. Survival data were analyzed using Kaplan-Meier’s method.
(C) Clinicopathological correlation of miR-210 in human HCCs. miR-210 overexpression signiﬁcantly correlated with aggressive fea-
tures of human HCCs, including more-advanced tumor stage, presence of venous invasion, and absence of tumor encapsulation. miR-
210 expression levels (DDCT) were presented as the log2 ratio of miR-210 expression in HCCs, as compared to their corresponding
nontumorous livers (log2 ratio HCC/NT). Statistical signiﬁcance was determined by t test. (D) Transwell cell invasion assays of
SMMC7721 and BEL-7402 were performed after transduction with miR-210 or empty vector lentivirus. Quantitative data are pre-
sented as mean 6 SD, and statistical signiﬁcance was determined by t test (*P < 0.05; **P < 0.01; ***P < 0.001). Results were from
three independent experiments. Successful overexpression of miR-210 was conﬁrmed by qPCR. U6 was used as housekeeping gene
for data normalization. Abbreviation: NT, nontumorous.
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mechanism enhancing metastatic potential of HCC
cells. Indeed, we observed that suppression of TIMP2
was contributed to by a novel feedback signaling circuit
that involves HIF-1a, miR-210, and HIF-3a.
HIF-1a and/or HIF-2a are frequently elevated in
human malignancies and their up-regulation is associ-
ated with poor prognosis of patients. On the contrary,
HIF-3a was found to be frequently down-regulated in
renal cell carcinomas.(23,24) Given its ability to inhibit
the transactivation of HRE-driven genes under hy-
poxic conditions, HIF-3a has been classiﬁed as a
dominant-negative regulator of HIF-1a/HIF-2a.
HIF-3a can form an inactive complex with HIF-1a or
HIF-2a and thus prevents their interaction with other
transcriptional components.(22,24) In the present study,
we found that TIMP2 down-regulation was under the
regulation of HIF-1a and miR-210 was directly up-
regulated by HIF-1a under hypoxic conditions in
HCC. Signiﬁcantly, we further validated HIF-3a as a
direct target of miR-210. Hence, the hypoxic induc-
tion of miR-210 might mediate positive feedback sig-
nal on HIF-1a by reducing expression of HIF-3a.
Importantly, the transcriptional activity of HIF-1a was
substantially abolished upon miR-210 inhibition,
implicating that hypoxic induction of miR-210 plays a
key role in enhancing the activity of HIF-1a under
hypoxic conditions, possibly by targeting HIF-3a. Fur-
thermore, we found that forced expression of HIF-3a
without 30UTR signiﬁcantly reduced the abundance of
miR-210.
In addition, we observed that miR-210 enhanced
the invasive ability of HCC cells. Similar observation
was reported in the previous study of Liang et al., who
demonstrated that miR-210 plays a prometastatic role
in HCC, and they attributed this effect to suppression
of vacuole membrane protein 1 (VMP1).(25) Neverthe-
less, the underlying biological mechanism by which
suppression of VMP1 promotes cancer cell invasion
remains poorly understood, given that VMP1 was well
established as a regulator of autophagy and apoptosis
rather than a suppressor of metastasis.(26,27) Therefore,
whether miR-210 enhances cancer metastasis through
targeting VMP1 remains unclear in HCC.
Currently, little information is available to address the
underlying mechanism by which hypoxia triggers
invadopodia-mediated ECM degradation in cancer cells.
One recent report demonstrated that the HIF system
contributed to invadopodia-mediated ECM remodeling
through activation of proto-oncogene tyrosine-protein
kinase SRC to promote melanoma metastasis. This pro-
vided the ﬁrst evidence supporting the regulatory role for
HIF in this aspect.(17) On the surface of invasive cancer
cells and tumor-associated endothelium, MMP2 is
known to interact with avb3 integrin receptor, and this
interaction facilitates cancer cell invasion by promoting
collagen degradation in the ECM.(28) TIMPs are the
most important physiological inhibitors of MMP activ-
ity. Among all family members of TIMPs, TIMP2 is
more effective in regulating the activity of MMP2.(29)
TIMP2 was previously demonstrated to be targeted by
miR519d in HCC.(30) However, in the present study,
we did not observe miR519d up-regulation in hypoxic
HCC cells. Instead, our study provided mechanistic evi-
dence that the HIF-1a/miR-210/HIF-3a feedback cir-
cuit plays a regulatory role in TIMP2 suppression.
Therefore, it is conceivable to believe that this feedback
circuit represents a novel mechanism linking hypoxia to
invadopodia-mediated ECM remodeling through stim-
ulation of MMP2 in hypoxic HCC cells.
Our ﬁndings have provided evidence that, under
hypoxic conditions, TIMP2 is a critical mediator of
HCC cell invasion and is under regulation of the
dynamic HIF-1a/miR-210/HIF-3a signaling circuit
(Fig. 6D). These ﬁndings have clinical relevance to the
transarterial chemoembolization (TACE) therapy
employed to block the hepatic arterial blood supply as
a treatment for HCC patients. Although most tumor
cells are starved to death under the nutrient-deprived
and oxygen-deprived conditions during TACE, it has
been suggested that the hypoxic insult might provide a
strong selection for the most metastatic tumor cells,
resulting in unsatisfactory long-term survival beneﬁts
in some patients.(31,32) From a recent study using a
preclinical HCC model, it has been demonstrated that
combination of TAE with antisense oligonucleotides
against HIF-1a inhibited tumor angiogenesis and fur-
ther promoted the tumor shrinkage effect.(33) Our data
in this study demonstrated that perturbation of the
dynamic HIF-1a signaling circuit by miR-210 inhibi-
tor abolished TIMP2 down-regulation and suppressed
HCC cell invasion. These ﬁndings support the notion
TABLE 2. Correlation of miR210, mRNA, and TIMP2
Protein Levels in Human HCC
No. of Cases
Without TIMP2
Underexpression
No. of Cases
With TIMP2
Underexpression
P
Value
miR210 overexpression
No 26 11 0.018
Yes 6 12
* Fisher’s exact test.
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that targeting against HIF-1a signaling is a promising
direction to tackle the hypoxic responses in HCC eli-
cited by TACE. Further investigation is warranted to
examine the feasibility of miR-210 inhibition as a
novel therapeutic strategy in combination with TACE
to suppress metastasis in hypoxic HCC cells.
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FIG. 6. Enhanced cell invasive ability conferred by TIMP2 suppression in hypoxia was perturbed by miR-210 inhibition. Transwell
cell invasion assays of (A) SMMC7721 and (B) PLC/PRF/5 were performed after transfection with miR-210 LNA inhibitor or nega-
tive control (NC) LNA inhibitor under normoxia (20% O2) or hypoxia conditions (0.1% O2). (C) Quantitative data are presented as
mean 6 SD, and statistical signiﬁcance was determined by t test (*P < 0.05; **P < 0.01; ***P < 0.001). Results were from three inde-
pendent experiments. (D) Schematic representation of the relationship between TIMP2 and the HIF-1a/miR-210/HIF-3a regulatory
feedback circuit in HCC metastasis. Abbreviation: NC, negative control.
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